Abstract
Since the mast cell is the only cell type possessing a specific recognition unit, IgE, for a foreign substance and located in the tissues in general rather than in a circulation, hematogenous or lymphatic, the physiologic role of this cell in host defense may be to recruit proteins and cells from the circulation in the absence of appreciable local tissue injury. After immunologic activation the mast cell elaborates mediators that alter the microenvironment so as to achieve the influx of plasma proteins, including immunoglobulins and complement components, and the ingress of phagocytic tissue and peripheral blood cells to the locus of the reaction.
Supported by grants AI-07722 and AI-10356 from the National Institutes of Health.
Postdoctoral Fellow of The Arthritis Foundation.
Investigator, Howard Hughes Medical Institute.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen, E., and Roy, A.B. 1968. The sulfatase of ox liver. XI. The isoelectric focusing of a purified preparation of sulfatase B. Biochim. Biophys. Acta 168:243.
Baker, A.R., Bloch, K.J., and Austen, K.F. 1964. In vitro passive sensitization of chopped guinea pig lung by guinea pig 7S antibodies. J. Immunol, 93;525.
Baum, H., Dodgson, K.S., and Spencer, B. 1959. The assay of arylsulfatase A and B in human urine. Clin. Chim. Acta 4:453.
Benveniste, J. 1974. Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils. Nature 249:581.
Benveniste, J., Henson, P.M., and Cochrane, C.G. 1972. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J. Exp. Med. 136:1356.
Benveniste, J., Kamoun, P., and Polonsky, J. 1975. Aggregation of human platelets by purified platelet activating factor from human and rabbit basophils. Fed. Proc. 34:985 (abstract).
Bleszynski, W., Leznicki, A., and Lewosz, J. 1969. Kinetic properties of three soluble arylsulfatases from ox brain, homogeneous in polyacrylamide gel electrophoresis. Enzymologica 37:314.
Bleszynski, W.S., and Roy, A.B. 1973. Some properties of sulfatase B of ox brain. Biochim. Biophys. Acta 317:164.
Black, J.W., Duncan, W.A.M., Durant, C.J., Cannellin, C.R., and Parson, E.M. 1972. Definition and antagonism of histamine H2-receptors; Nature 236:385.
Bloom, G., and Ringertz, N.R. 1961. Acid polysaccharides of peritoneal mast cells of the rat and mouse. Arkiv för Kemi 16:51.
Bogart, D.B., and Stechschulte, D.J. 1974. Release of platelet activating factor from human lung. Clin. Res. 22:652 (abstract).
Boyden, S. 1962. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J. Exp. Med. 115:453.
Böyum, A. 1968. Isolation of leucocytes from human blood, further observations. Scand. J. Clin. Lab. Invest. 21: (Suppl. 97):31.
Breslow, J.C., and Sloan, H.F. 1972. Purification of arylsulfatase A from human urine. Biockem. Biophys. Res. Commu. 46:919.
Brocklehurst, W.E. 1960. The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J. Physiol. 151:416.
Brocklehurst, W.E. 1962. Slow reacting substance and related compounds. Progr. Alierg. 6:539.
Citron, K.M., Frankland, A.W., and Sinclair, J.D. 1958. Inhalation tests of broncho-hypersensitivity in pollen asthma. Thorax 13:229.
Clark, R.A., Gallin, J.I., and Kaplan, A.P. 1975. The selective eosinophil chemotactic activity of histamine. J. Exp Med. 142:1462.
Damus, P.S., Hicks, M., and Rosenberg, R.D. 1973. Anticoagulant action of heparin. Nature 246:355.
DiAugustine, R.P. 1974. Lung concentric laminar organelle: Hydrolase activity and compositional analysis. 249:584.
Dodgson, K.S., and Spencer, B. 1957. Assay of sulfatases. Meth. Biochem. Analysis 4:211.
Dodgson, K.S., Spencer, B., and Thomas, J. 1955. Studies on sulfatases. 9. The arylsulfatase of mammalian liver. Bio chem. J. 59:29.
Dodgson, K.S., Spencer, B., and Wynn, C.H. 1956. The arylsulfatases of human tissues. Biochem. J. 62:500.
Dolovich, J., Hargreave, F.E., Chalmers, R., Shier, K.J., Gauldie, J., and Bienenstock, J. 1973. Late cutaneous allergic responses in isolated IgE-dependent reactions. J. Allergy Clin. Immunol. 49:43.
Drazen, J.M., and Austen, K.F. 1974. Effects of intravenous administration of slow reacting substance of anaphylaxis, histamine, bradykinin, and prostaglandin F2αon pulmonary mechanics in the guinea pig. J. Clin. Invest. 53:1679.
Drazen, J.M., and Austen, K.F. 1975. Atropine modification of the pulmonary effects of chemical mediators in the guinea pig. J. Appl. Physiol. 38:834.
Feltkamp-Vroon, T.M., Stallman, P.J., Analberse, R.C., and Reerink-Bronkers, E.E. 1975. Immunofluorescence studies on renal tissue, tonsils, adenoids, nasal polyps, and skin of atopic and non-atopic patients with special reference to I. Clin. Immunol. Immunopathol. 4:392.
Fillion, G.M.B., Storach, S.A., and Uvnäs, B. 1970. The release of histamine, heparin and granule protein from rat mast cells treated with compound 48/80 in vitro. Acta Physiol. Scand. 78:547.
Fraenkel-Conrat, H., and Tsung, C.M. 1967. Hydrazinolysis. In: METHODS IN ENZYMOLOGY, Vol. XI, p. 151, (C.H.W. Hirs, ed.) Academic Press, New York.
Goetzl, E.J., and Austen, K.F. 1972. A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization. J. Exp. Med. 136:1564.
Goetzl, E.J., and Austen, K.F. 1975. Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: Identification as eosinophil chemotactic factor of anaphylaxis. Proc. Natl. Acad. Sci. 72:4123.
Goetzl, E.J., Rubin, R.H., Monough, J., Tashjian, A.H., and Austen, K.F. 1976. Production of eosinophilotactic peptides by bronchogenic carcinoma in situ and in vitro. J. Clin. Invest (abstract), in press.
Grant, J.A., and Lichtenstein, L.M. 1974. Release of slow reacting substance of anaphylaxis from human leukocytes. J. Immunol. 112:897.
Gray, W.R. 1967. Sequential degradation plus dansylation. In: METHODS IN ENZYMOLOGY, Vol. XI, p. 469, (C.H.W. Hirs, ed.) Academic Press, New York.
Gutte, B., and Merrifield, R.B. 1971. The synthesis of ribonuclease A. J. Biol. Chem. 246:1922.
Hargreave, F.E., and Pepys, J. 1972. Allergic respiratory reactions in bird fanciers provoked by allergen inhalation provocation tests. Relation to clinical features and allergic mechanism. J. Allergy Clin. Immunol. 50:157.
Hargreave, F.E., Pepys, J., Longbottom, J.L., and Wraith, D.G. 1966. Bird breeder’s (fancier’s) lung. Lancet 1:44.
Harinath, B.C., and Robins, E. 1971. Arylsulfatase in human brain. Separation, purification and certain properties of the two soluble arylsulfatases. J. Neurochem. 18:245.
Hartley, B.S. 1970. Strategy and tactics in protein chemistry. Biochem. J. 119:805.
Highsmith, R.F., and Rosenberg, R.D. 1974. The inhibition of human plasmin by human antithrombin-heparin cofactor. J. Biol. Chem. 249:4335.
Hubscher, T. 1975. Role of the eosinophil in the allergic reactions. I. EDI - An eosinophil-derived inhibitor of histamine release. J. Immunol. 114:1379.
Jaques, L.B., Monkhouse, F.C., and Steward, M. 1949. A method for the determination of heparin in blood. J. Physiol. 109:41.
Jefry, A., and Roy, A.B. 1973. The sulfatase of ox liver. XVI. A comparison of the arylsulfatase and cerebroside sulfatase activities of arylsulfatase A. Biochim. Biophys. Acta 293:178.
Kaliner, M., and Austen, K.F. 1973. A sequence of biochemical events in the antigen-induced release of chemical mediators from sensitized human lung tissue. J. Exp. Med. 138:1077.
Kaliner, M., and Austen, K.F. 1974a. Hormonal control of the immunologic release of histamine and slow reacting substance of anaphylaxis from human lung. In: CYCLIC AMP, CELL GROWTH, AND THE IMMUNE RESPONSE, p. 163, (W. Braun, L.M. Lichtenstein, and C.W. Parker, eds.) Springer-Verlag, New York.
Kaliner, M., and Austen, K.F. 1974b. Cyclic AMP, ATP, and reversed anaphylactic histamine release from rat mast cells. J. Immunol. 112:664.
Kaliner, M., Orange, R.P., and Austen, K.F. 1972. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. IV. Enhancement by cholinergic and alpha adrenergic stimulation. J. Exp. Med. 136:556.
Kaliner, M., Wasserman, S.I., and Austen, K.F. 1973. Immunologic release of chemical mediators from human nasal polyps. New Engl. J. Med. 289:277.
Kater, L.A., Goetzl, E.J., and Austen, K.F. 1976. Isolation of human eosinophil phospholipase D. J. Clin. Invest., in press.
Kay, A.B., and Austen, K.F. 1971. The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J. Immunol. 107:899.
Kay, A.B., Stechschulte, D.J., and Austen, K.F. 1971. An eosinophil leukocyte cnemotactic factor of anaphylaxis. J. Exp. Med. 133:602.
Kravis, T.C., and Henson, P.M. 1975. IgE-induced release of a platelet-activating factor from rabbit lung. J. Immunol. 115:1677.
Lewis, R.A., Wasserman, S.I., Goetzl, E.J., and Austen, K.F. 1974. Formation of SRS-A in human lung tissue and cells before release. J. Exp. Med. 140:1133.
Lewis, R.A., Goetzl, E.J., Wasserman, S.I., Valone, F.H., Rubin, R.H., and Austen, K.F. 1975. The release of four mediators of immediate hypersensitivity from human leukemic basophils. J. Immunol. 114:87.
Lichtenstein, L.M., and Gillespie, E. 1975. The effects of the H1 and H2 antihistamines on “allergic” histamine release and its inhibition by histamine. J. Pharmacol. Exp. Ther. 192:441.
Lloyd, A.G., Bloom, G.D., and Balazs, E.A. 1967a. Evidence for the covalent association of heparin and protein in mast-cell granules. Biochem. J. 103:76.
Lloyd, A.G., Bloom, G.D., Balazs, E.A., and Haegermark, O.1967b. Combined biochemical and morphological ultrastructure studies on mast-cell granules. Biochem. J. 103:75.
Matsuo, H., Fujimoto, Y., and Tatsuno, T. 1966. A novel method for the determination of C-terminal amino acid in polypeptides by selective tritium labelling. Biochem. Biophys. Res. Commun. 22:69.
McCarthy, D.S., and Pepys, J. 1971. Allergic bronchopulmonary aspergillosis. Clinical Immunology: (2) Skin, nasal, and bronchial tests. Clin. Allergy 1:415.
Mehl, E., and Jatzhewitz, H. 1968. Cerebroside 3-sulfate as a physiological substrate of arylsulfatase A. Biochim. Biophys. Acta 151:619.
Morse, H.C., III, Bloch, K.J., and Austen, K.F. 1968. Biologic properties of rat antibodies. II. Time-course of appearance of antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-Arat); association of this activity with rat IgGa. J. Immunol. 101:658.
Neuwelt, E., Stumpf, D., Austin, J., and Kohler, P. 1971. A monospecific antibody to human sulfatase A: Preparation, characterization and significance. Biochim. Biophys. Acta 236:333.
Nichol, L.W., and Roy, A.B. 1965. The sulfatase of ox liver. IX. The polymerization of sulfatase A. Biochemistry 4:386.
Odegard, O.R., Lie, M., and Abildgaard, U. 1975. Heparin cofactor activity measured with an amidolytic method. Thrombosis Res. 6:287.
Orange, R.P. 1973. Immunopharmacological aspects of bronchial asthma. Clin. Allergy 3:(Supplement):521.
Orange, R.P. 1974. The formation and release of slow reacting substance of anaphylaxis in human lung tissues. In: PROGRESS IN IMMUNOLOGY II, Vol. 4, p. 29 (L. Brent and J. Holborow, eds.) North Holland Publishing Co., Amsterdam.
Orange, R.P., Stechschulte, D.J., and Austen, K.F. 1969. Cellular mechanisms involved in the release of slow reacting substance of anaphylaxis. Fed. Proc. 28:1710.
Orange, R.P., Stechschulte, D.J., and Austen, K.F. 1970. Immunochemical and biologic properties of rat IgE. II. Capacity to mediate the immunologic release of histamine and slow reacting substance of anaphylaxis (SRS-A). J. Immunol. 105:1087.
Orange, R.P., Austen, W.G., and Austen, K.F. 1971. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3’,5’-adenosine monophosphate. J. Exp. Med. 134:136s.
Orange, R.P., Murphy, R.C., Karnovsky, M.L., and Austen, K.F.1973. The physicochemical characteristics and purification of slow reacting substance of anaphylaxis. J. Immunol. 110:760.
Orange, R.P., Murphy, R.C., and Austen, K.F. 1974. Inactivation of slow reacting substance of anaphylaxis (SRS-A) by arylsulfatases. J. Immunol. 113:316.
Paterson, N.A.M., Wasserman, S.I., Said, J., Kater, L.A., and Austen, K.F. 1976. Mediator release from human lung cells distributed according to density. Fed. Proc. (abstract), in press.
Patterson, R., and Suszko, I.M. 1971. Primate respiratory mast cells. Reactions with ascaris antigen and anti-heavy chain sera. J. Immunol. 106:1274.
Patterson, R., Tomita, Y., Oh, S.H., Suszko, I.M., and Pruzansky, J.J. 1974. Respiratory mast cells and basophiloid cells. I. Evidence that they are secreted into the bronchial lumen, morphology, degranulation, and histamine rselease. Clin. Exp. Immunol. 16:223.
Payne, W.J., Fitzgerald, J.W., and Dodgson, K.S. 1974. Methods for visualization of enzyme in polyacrylamide gels. Appl. Microbiol. 27:154.
Pepys, J., Turner-Warwick, M., Dawson, P.L., and Hinson, K.R.W. 1968. Arthus (type III) skin test reactions in man. Clinical and immunopathological features. In: ALLERGOLOGY, p. 221, (B. Rose, R. Richter, A. Sehon, and A.W. Frankland, eds.) Excerpta Medica Foundation, No. 162, Amsterdam.
Rent, R., and Fiedel, B. 1975. Effect of heparin on Cl-esterase inhibitor (Cl-INH). Fed. Proc. 34:964 (abstract).
Riley, J.F., and West, G.B. 1953. The presence of histamine in tissue mast cells. J. Physiol. 120:528, 1953.
Rosenberg, R.D., and Damus, P.S. 1973. Purification and mechanism of action of human antithrombin-heparin cofactor. J. Biol. Chem. 248:6490.
Roy, A.B. 1957. Sulfatase of ox liver. I. Complex nature of the enzyme. Biochem. J. 53:12.
Roy, A.B. 1970. The product inhibition of sulfatase B. Biochim. Biophys. Acta 198:365.
Roy, A.B. 1971. The type II arylsulfatase of the red kangaroo. Biochim. Biophys. Acta. 227:129.
Schayer, R.W. 1959. Catabolism of physiological quantities of histamine in vivo. Physiol. Rev. 39:116.
Shapna, E., and Nadier, H.L. 1975. Purification and some properties of soluble human liver arylsulfatases. Arch. Biochem. Biophys. 170:179.
Siraganian, R.P., and Osier, A.G. 1971. Destruction of rabbit platelets in the allergic response of sensitized leukocytes. I. Evidence of basophil involvement. J. Immunol. 106:1252.
Spackman, D.H., Stein, W.H., and Moore, S. 1958. Automatic recording apparatus for use in the chromatography of amino acids. Anal. Chem. 30:1490.
Stevens, R.L., Fluharty, A.L., Skokut, M.H., and Kihara, H. 1975. Purification and properties of arylsulfatase A from human urine. J. Biol. Chem. 250:2495.
Stewart, J.M., and Young, J.P. 1969. SOLID PHASE PEPTIDE SYNTHESIS, W.H. Freeman and Co., San Francisco.
Standberg, K., and Hedqvist, P. 1975. Airway effects of slow reacting substance, prostaglandin F2αand histamine in the guinea pig. Acta Physiol. Scand. 9:105.
Tauber, A.I., Kaliner, M., Stecnschulte, D.J., and Austen, K.F. 1973. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. V. Effects of prostaglandins on release of histamine. J. Immunol. 111:27.
Taylor, G., and Shivalkar, P.R. “Arthus-type” reactivity in the nasal airways and skin in pollen sensitive subjects. Clin. Allergy 1:407.
Ward, P.A., and Becker, E.L. 1968. The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase. J. Exp. Med. 127:693, 1968.
Wasserman, S.I., and Austen, K.F. 1976. Arylsulfatase B of human lung: Isolation, characterization and interaction with slow reacting substance of anaphylaxis. J. Clin. Invest., in press.
Wasserman, S.I., Goetzl, E.J., and Austen, K.F. 1974a. Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A). J. Immunol. 112:351.
Wasserman, S.I., Goetzl, E.J., Ellman, L., and Austen, K.F. 1974b. Tumor associated eosinophilotactic factor. New Engl. J. Med. 290:420.
Wasserman, S.I., Goetzl, E.J., and Austen, K.F. 1975a. Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase. J. Immunol. 114:645.
Wasserman, S.I., Whitmer, D., Goetzl, E.J., and Austen, K.F. 1975b. Chemotactic deactivation of human eosinophils by eosinophil chemotactic factor of anaphylaxis. Proc. Soc. Exp. Biol. Med. 148:301.
Wasserman, S.I., Goetzl, E.J., and Austen, K.F. 1975c. Inactivation of human SRS-A by intact human eosinophils and by eosinophil arylsulfatase. J. Allergy Clin. Immunol.55:72 (abstract).
Wasserman, S.I., Boswell, R.N., Drazen, J.M., Goetzl, E.J., and Austen, K.F. 1976a. Functional specificity of the human lung acidic tetrapeptides constituting eosinophil chemotactic factor of anaphylaxis (ECF-A). J. Allergy Clin. Immunol, (abstract), in press.
Wasserman, S.I., Soter, N.A., Center, D.M., and Austen, K.F. 1976b. Cold urticaria: The appearance in the circulation of a neutrophil chemotactic principle during cold challenge. Clin. Res. (abstract), in press.
Woods, K.R., and Wang, K.T. 1967. Separation of dansyl-amino acids by polyamide layer chromatography. Biochim. Biophys. Acta 133:369.
Yin, E.T., Wessler, S., and Stoll, P.J. 1971. Identity of plasma-activated factor X inhibitor with antithrombin III and heparin cofactor. J. Biol. Chem. 246:3712.
Yurt, R.W., Leid, R.W., Silbert, J.E., Spragg, J., and Austen, K.F. 1976. Immunologic release of heparin from purified rat peritoneal mast cells. Fed. Proc. (abstract), in press.
Zeiger, R.S., Yurdin, D.L., and Colten, H.R. 1976. Histamine metabolism: II. Cellular and subcellular localization of the catabolic enzymes, histaminase and histamine methyl transferase in human leukocytes. J. Allergy Clin. Immunol., in press.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Austen, K.F., Wasserman, S.I., Goetzl, E.J. (1976). Mast Cell-Derived Mediators: Structural and Functional Diversity and Regulation of Expression. In: Johansson, S.G.O., Strandberg, K., Uvnäs, B. (eds) Molecular and Biological Aspects of the Acute Allergic Reaction. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4304-2_15
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4304-2_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4306-6
Online ISBN: 978-1-4613-4304-2
eBook Packages: Springer Book Archive